125 related articles for article (PubMed ID: 38606776)
1. Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension.
Chay J; Jafar TH; Su RJ; Shirore RM; Tan NC; Finkelstein EA
J Am Heart Assoc; 2024 Apr; 13(8):e033631. PubMed ID: 38606776
[TBL] [Abstract][Full Text] [Related]
2. Management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: The SingHypertension cluster randomized trial.
Jafar TH; Tan NC; Allen JC; Finkelstein EA; Goh P; Moey P; Quah JHM; Hwang SW; Bahadin J; Thiagarajah AG; Chan J; Kang G; Koong A
Trials; 2018 Mar; 19(1):180. PubMed ID: 29540213
[TBL] [Abstract][Full Text] [Related]
3. Integration of a multicomponent intervention for hypertension into primary healthcare services in Singapore-A cluster randomized controlled trial.
Jafar TH; Tan NC; Shirore RM; Allen JC; Finkelstein EA; Hwang SW; Koong AYL; Moey PKS; Kang GC; Goh CWT; Subramanian RC; Thiagarajah AG; Ramakrishnan C; Lim CW; Liu J;
PLoS Med; 2022 Jun; 19(6):e1004026. PubMed ID: 35696440
[TBL] [Abstract][Full Text] [Related]
4. Statistical analysis plan for management of hypertension and multiple risk factors to enhance cardiovascular health in Singapore: the SingHypertension pragmatic cluster randomized controlled trial.
Allen JC; Halaand B; Shirore RM; Jafar TH;
Trials; 2021 Jan; 22(1):66. PubMed ID: 33468225
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and budget impact of the community-based management of hypertension in Nepal study (COBIN): a retrospective analysis.
Krishnan A; Finkelstein EA; Kallestrup P; Karki A; Olsen MH; Neupane D
Lancet Glob Health; 2019 Oct; 7(10):e1367-e1374. PubMed ID: 31537367
[TBL] [Abstract][Full Text] [Related]
6. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR).
Penaloza-Ramos MC; Jowett S; Mant J; Schwartz C; Bray EP; Sayeed Haque M; Richard Hobbs FD; Little P; Bryan S; Williams B; McManus RJ
Eur J Prev Cardiol; 2016 Jun; 23(9):902-12. PubMed ID: 26603745
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a Multicomponent Intervention for Hypertension Control in Low-Income Settings in Argentina.
Zhang Y; Yin L; Mills K; Chen J; He J; Palacios A; Riviere AP; Irazola V; Augustovski F; Shi L
JAMA Netw Open; 2021 Sep; 4(9):e2122559. PubMed ID: 34519769
[TBL] [Abstract][Full Text] [Related]
9. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
[TBL] [Abstract][Full Text] [Related]
10. Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial.
Lung T; Jan S; de Silva HA; Guggilla R; Maulik PK; Naik N; Patel A; de Silva AP; Rajapakse S; Ranasinghe G; Prabhakaran D; Rodgers A; Salam A; Selak V; Stepien S; Thom S; Webster R; Lea-Laba T;
Lancet Glob Health; 2019 Oct; 7(10):e1359-e1366. PubMed ID: 31477545
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Intensive vs Standard Blood Pressure Control Among Older Patients With Hypertension.
Liao CT; Toh HS; Sun L; Yang CT; Hu A; Wei D; Melgarejo J; Zhang ZY
JAMA Netw Open; 2023 Feb; 6(2):e230708. PubMed ID: 36848091
[TBL] [Abstract][Full Text] [Related]
13. Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program.
Rosendaal NT; Hendriks ME; Verhagen MD; Bolarinwa OA; Sanya EO; Kolo PM; Adenusi P; Agbede K; van Eck D; Tan SS; Akande TM; Redekop W; Schultsz C; Gomez GB
PLoS One; 2016; 11(6):e0157925. PubMed ID: 27348310
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of hypertension therapy based on 2020 International Society of Hypertension guidelines in Ethiopia from a societal perspective.
Davari M; Sorato MM; Kebriaeezadeh A; Sarrafzadegan N
PLoS One; 2022; 17(8):e0273439. PubMed ID: 36037210
[TBL] [Abstract][Full Text] [Related]
15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
16. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Intensive Versus Standard Blood Pressure Treatment in Older Patients With Hypertension in China.
Fan J; Zheng W; Liu W; Xu J; Zhou L; Liu S; Bai J; Qi Y; Huang W; Liu K; Cai J
Hypertension; 2022 Nov; 79(11):2631-2641. PubMed ID: 36177835
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study.
Constanti M; Floyd CN; Glover M; Boffa R; Wierzbicki AS; McManus RJ
Hypertension; 2021 Feb; 77(2):682-691. PubMed ID: 33342242
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a mobile technology-enabled primary care intervention for cardiovascular disease risk management in rural Indonesia.
Angell B; Lung T; Praveen D; Maharani A; Sujarwoto S; Palagyi A; Oceandy D; Tampubolon G; Patel A; Jan S
Health Policy Plan; 2021 May; 36(4):435-443. PubMed ID: 33712844
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
